The Kar-Jenner sisters, particularly Kim Kardashian, have long faced claims of usingOzempic, a drug originally for diabetes that became popular for weight loss in 2022. Now, Kourtney Kardashian Barker's supplement brand, Lemme,is under fire for launching an "Ozempic-style" weight-loss supplement, accused of capitalizing on the drug's hype.

Ozempic is a weekly injectable medication containing a synthetic version of the GLP-1 hormone, naturally released by the body after eating. When injected, this man-made hormone slows digestion, reduces hunger, and aids in shedding body weight. Several celebrities, including Lottie Moss who experienced a violent seizure from an overdose, have admitted to using it.

Photo Credit: Page Six Style

Lemme's new product, GLP-1 Daily, directly references the Ozempic hormone. Marketed to "reduce body weight, visceral fat, and hip and waist circumference," the pill claims to be a natural replacement for the jab. While Kourtney hasn't explicitly compared her product to Ozempic, she promoted an article discussing her desire to be "in on the Ozempic boom." The Lemme pill aims to naturally increase GLP-1 levels using lemon and saffron extracts, unlike synthetic GLP-1s in injectables. Brand emails describe it as a "GLP-1 solution without the side effects" of Ozempic.

However, fans and medical experts alike have criticized Kourtney, who has previously advocated for body positivity. Critics on social media called it a "facade and false marketing," arguing that oral supplements cannot mimic GLP-1 medications effectively for weight loss due to rapid enzyme degradation. A one-time purchase costs £69, with a monthly subscription at £55.23, leading to accusations of a "cash grab" that exploits insecurities.

Plastic surgeonNaveen Cavale of Real Plastic Surgery slammed Lemme's GLP-1 Daily as "incredibly misleading" and potentially exacerbating mental health issues, particularly for Gen Z customers struggling with body image. He stated that while marketed as a natural alternative, it lacks the scientifically proven impact of injectable medications like Ozempic, which contain semaglutide – a rigorously tested GLP-1 receptor. Cavale emphasized that effective weight loss solutions require consulting medical professionals, warning that ineffective products can lead to frustration, feelings of failure, anxiety, stress, and depression.

Furthermore, Lemme's small print reveals that its claims have not been evaluated by the Food and Drug Administration (FDA), stating the product is "not intended to diagnose, treat, cure or prevent any disease." The FDA ensures the safety and efficacy of drugs, vitamins, supplements, and medical devices, and its approval signifies thorough testing.

Photo Credit: Pinterest

This isn't Lemme's first controversy. Kourtney, known as the most health-conscious Kardashian sister, launched Lemme in September 2022, citing her son Mason's birth as inspiration for her wellness journey. However, the brand's prior products, Lemme Purr (vagina gummies marketed to boost health and alter taste) and Lemme Smooth (capsules claiming to reduce cellulite in 28 days), also faced significant backlash. Gynaecologist Dr. Jen Gunter called Lemme Purr a "misogynist and awful" "grift," disputing the idea that vaginas need freshness or taste alteration. Similarly, plastic surgeonMr. Naveen Cavaledismissed Lemme Smooth as "a fad" lacking scientific backing, urging women to embrace cellulite as a natural condition rather than seeking unproven and costly remedies.

These controversies highlight concerns that Lemme's products capitalize on societal pressures and body insecurities by offering quick-fix solutions without sufficient scientific validation, potentially misleading consumers and negatively impacting mental well-being.